<p><strong>Interlaboratory comparisons (ILCs) have been used for more than a century and many important concepts are linked to them. This leaflet addresses the basic terminology of ILCs, why some colloquial terms can be misleading or misunderstood, and the importance of harmonisation.&nbsp;</strong></p><p>An ‘ILC’ is the <i>organisation, performance and evaluation of measurements or tests on the same or similar items by two or more laboratories in accordance with predetermined conditions</i> [1]. ILCs have a variety of overall – and detailed – objectives, the three most common [2] being:</p><p><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Eurachem_Let_s_call_a_PT_scheme_a_PT_scheme_3_9993b9fb0f.jpg" alt="Eurachem: Let’s call a PT scheme a PT scheme" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Eurachem_Let_s_call_a_PT_scheme_a_PT_scheme_3_9993b9fb0f.jpg 245w," sizes="100vw" width="1516" height="472"></p><h4><strong>Some comparisons have special names&nbsp;</strong></h4><p>The evaluation of participant (laboratory, organisation or individual) performance is typically referred to as ‘<strong>proficiency testing</strong>’ (PT) or ‘<strong>external quality assessment</strong>’ [1]. When the main objective is evaluating the performance of, for example, a candidate standard method, the ILC is often called a ‘<strong>method performance study</strong>’ or a ‘<strong>collaborative study</strong>’ [2, 3]. The former is quite clear whereas wording such as “<strong>collaborative</strong>” and “<strong>cooperative</strong>” just stresses joint effort. A project aimed at producing a new certified reference material may involve several laboratories conducting analyses on agreed properties [4]. Not surprisingly, this work is sometimes labelled as a ‘<strong>material certification study</strong>’. Special ILCs used to demonstrate measurement capabilities of National Metrology Institutes are called ‘<strong>key comparisons</strong>’, ‘<strong>supplementary comparisons</strong>’, and ‘<strong>pilot studies</strong>’ [5].&nbsp;</p><h4><strong>Some terms can be confusing&nbsp;</strong></h4><p>Other terms for ILCs, including ‘ring test’, ‘round robin’ and ‘circle analysis’, are common in the literature. They have, however, been used for different objectives and different designs and may be ambiguous or understood differently by laboratory staff. The use of these terms may, for example, imply a specific way of distributing the ILC sample. ISO/IEC 17043 uses ‘sequential scheme’, for a PT where a unique item is transferred between the participants and ‘simultaneous scheme’, in which similar items from a batch are distributed simultaneously to the participants [1].&nbsp;</p><p>Terms like ‘<strong>measurement audit</strong>’, ‘<strong>interlaboratory testing scheme</strong>’, ‘<strong>measurement comparison scheme</strong>’, ‘<strong>rapid performance evaluation scheme</strong>’ and ‘<strong>intercalibration</strong>’ may not correctly reflect the category of laboratory involved, or the type of work participants do during the ILC.&nbsp;</p><p>When in 1994 the IUPAC defined and described three major types of ‘interlaboratory studies’, the word ‘study’ was preferred to synonyms such as ‘trial’, ‘exercise’, ‘test’, ‘evaluation’ or ‘check’ [2].</p><h4><strong>Let’s try to harmonise&nbsp;</strong></h4><p>Many laboratory staff are unaware of official terms related to ILCs but recognise the acronym PT and words like ‘ring test’. Ideally, we would use a common scientific language, but harmonisation is time consuming. Terms appear and disappear and definitions change. The same term can be defined differently, even in different international standards. Lack of standards and guidelines in local languages can cause confusion and contribute to spreading of less appropriate terms.&nbsp;</p><p><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Eurachem_Let_s_call_a_PT_scheme_a_PT_scheme_2_820043ce8b.jpg" alt="Eurachem: Let’s call a PT scheme a PT scheme" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Eurachem_Let_s_call_a_PT_scheme_a_PT_scheme_2_820043ce8b.jpg 234w," sizes="100vw" width="1006" height="671"></p><p>Much confusion can be avoided by clear reference to relevant standards and sectoral guides. ISO/ IEC 17043 [1] and ISO 13528 [6] contain many important concepts related to PT schemes and other ILCs. Some of these are also incorporated into ISO/IEC 17025 [7]. Additional useful, and free, tools are the Eurachem PT Guide [8] and the ISO online browsing platform [9].&nbsp;</p><p>In writing guidance and instructions, remember that the term ‘interlaboratory comparison’ has a broad meaning and can be used for all cases described above. Sometimes this is clear enough for the reader. In other cases, use acknowledged terms that reflect the detailed objective of the ILC. Let’s call a PT scheme a PT scheme!</p>

Let’s call a PT scheme a PT scheme!

<p><span><strong>The countdown is on for one of the world’s leading conferences dedicated to food analysis. The 12th International Symposium on Recent Advances in Food Analysis (RAFA 2026), taking place in Prague from 3–6 November 2026, is approaching two important milestones: the Early Bird registration deadline and the deadline for oral abstract submissions, both ending on 30 June 2026. Researchers, analysts, industry professionals, regulators, and students are encouraged to secure their participation at a reduced registration rate and take advantage of the opportunity to present their latest scientific results to the international food analysis community.</strong></span></p><p><span>RAFA 2026 will once again bring together leading experts from academia, industry, and regulatory organizations to discuss the latest developments in food safety, authenticity, contaminants, non-target screening, PFAS, microplastics, food contact materials, artificial intelligence, and advanced analytical technologies. The preliminary program already features an outstanding lineup of internationally recognized speakers addressing some of the most pressing challenges in modern food analysis and food safety.</span></p><h3><strong>Registration</strong></h3><blockquote><p class="cke-user_style-important"><strong>👉</strong><a target="_blank" rel="noopener noreferrer" href="https://rafa.easyevent.eu/tickets/"><strong>Register to attend RAFA 2026!</strong></a></p><p><strong>Early-bird registration until 30 June, 2026</strong></p></blockquote><p>After successful submission of your registration, you will receive by e-mail (i) an automatic confirmation of receipt indicating the total amount of payment due (either for bank transfer or for on-line payment by card), (ii) login to Member section where you can administrate your profile, submit your abstracts, and from <strong>September 2026</strong> register for satellite events, workshops and seminars. If it will not be delivered within a few minutes after submission of your registration please contact us at <strong>RAFA2026@vscht.cz</strong>.</p><p>As soon as payment of registration fee is processed, you will also receive by e-mail (iii) confirmation of payment.</p><h4><strong>Registration Fees</strong></h4><ul><li><strong>Smart rate (Until 30 June, 2026): </strong>€ 655</li><li><strong>Regular registration (Until 30 September, 2026):</strong> € 855</li><li><strong>Late registration (From 1 October, 2026):</strong> € 955</li><li><strong>Student rate*&nbsp;</strong><ul><li><strong>Until 30 June, 2026: </strong>€ 465</li><li><strong>From 1 July, 2026:</strong> € 605</li></ul></li></ul><p><i>* The proof of student status (e.g. copy of a student identify card) is requested as an attachment of the registration form.</i></p><h5><strong>The regular registration fee will include:</strong></h5><ul><li>Attendance at all scientific sessions, workshops, seminars, vendor seminars and other satellite events</li><li>Access to the poster and exhibition area</li><li>Conference kit (name badge, conference bag, conference documents, certificate of participation, certificate of presentation on request)</li><li>Final programme</li><li>E-Book of Abstracts</li><li>Coffee breaks</li><li>Buffet luncheons</li><li>Welcome drink</li></ul><p>In the registration form you can r<strong>egister free of charge for the welcome drink</strong> and you can also order <strong>ticket(s) for the conference dinner (€ 85).</strong></p><p><i>Please note that your registration is firm when your payment has been received.</i></p><h3><strong>Abstract submission</strong></h3><blockquote><p class="cke-user_style-important"><strong>👉</strong><a target="_blank" rel="noopener noreferrer" href="https://rafa.easyevent.eu/tickets/"><strong>Submit your ABSTRACT HERE!</strong></a></p><p>In order to submit an abstract, you must <strong>first register to attend RAFA 2026</strong>. <strong>After registration</strong> you will receive an <strong>access to the Member section </strong>where you can <strong>submit your abstract(s).</strong></p></blockquote><p>&nbsp;After successful submission of your abstract you will receive an automatic confirmation of receipt of submitted abstract via e-mail. If it will not be delivered within a few minutes after submission of your abstract please check at first your spam box-mail and then contact us at <strong>RAFA2026@vscht.cz</strong>.</p><p>Please ensure that your abstract does not contain spelling, grammatical or scientific errors. Even though modifications of your submitted abstract will be allowed in the Abstract section of the Member section until the deadline for the abstract submission, please be confident on the lack of errors in your final version prior to starting the submission process.</p><p>The abstract will be reproduced exactly as submitted. No proofreading will be done, although some corrections may be requested by the reviewers.</p><p>If you need to withdraw your abstract, a written statement reflecting the reasons for this decision must be sent to <strong>RAFA2026@vscht.cz</strong> no later than <strong>September 30, 2026</strong>.</p><h4><strong>Important notice:</strong></h4><blockquote><p><strong>1 registered participant can submit no more than 2 abstracts.</strong></p></blockquote><p>To apply for a young scientist’s oral presentation, as an indication please respect the rule that you should be born in 1991 or later.</p><p>The <strong>text of the abstract </strong>should be<strong> limited to 3000 characters including spaces</strong>. Tables and pictures are not allowed.</p><p><strong>Abstracts of oral presentations and posters</strong> will be included into the "<strong>e-Book of Abstracts</strong>" only after receipt of the conference registration fee. Any payment of the registration fee has to be received until <strong>September 30, 2026</strong>, otherwise contribution(s) will not be included into the e-Book of Abstracts and the Conference programme.</p><h3><strong>Program</strong></h3><h4><strong>Invited Speakers</strong></h4><h5><strong>Food allergen risk assessment: Past, present, future</strong></h5><ul><li>Ben Remington from Remington Consulting Group B.V., Utrecht, the Netherlands &amp; University of Nebraska, USA</li></ul><p>Food allergy and allergen management are global public health issues, and consumer protection depends on transparent and trustworthy labelling. While 30 years of scientific advances show that low level exposures, or reference doses, are unlikely to trigger reactions in most allergic individuals, harmonized and globally aligned regulations are still needed to promote consistent allergen risk assessment and labelling decisions. This presentation will discuss the landscape of allergen risk assessment, global policy developments, current research and future needs in the area.</p><h5><strong>Unmasking hidden adulteration in honey: Strategies for detecting and characterizing honeys produced from sugar-fed colonies</strong></h5><ul><li>Oscar Nuñez Burcio from University of Barcelona, Barcelona, Spain</li></ul><p>From hive to jar, not all honey tells the same story. This presentation addresses hidden adulteration associated with sugar-fed bee colonies, highlighting implications for authenticity, production practices, and the need for a more precise characterization of honey to ensure consumer trust.</p><h5><strong>Analytical and toxicological methods for safety of food contact materials</strong></h5><ul><li>Erich Leitner from Graz University of Technology, Institute of Analytical Chemistry and Food Chemistry, Graz, Austria</li></ul><p>Food packaging plays a critical role in protecting and preserving food throughout the supply chain. All packaging materials intended to come into contact with food must comply with strict EU safety rules. Due to increased complexity of packaging solutions, lowering legal limits and increasing numbers of target compounds, we also have to adapt the strategies used to verify and guarantee the safety of these materials.</p><h5><strong>Data-driven strategies to reduce complexity in non-target HRMS analysis of food samples</strong></h5><ul><li>Anneli Kruve from Stockholm University, Stockholm, Sweden</li></ul><p>LC/HRMS based non-target screening can detect hundreds to thousands of chemical features in complex food and environmental samples. Investigating all of these in detail is practically impossible, so which ones to focus on? Novel computational tools developed in computational mass spectrometry allow predicting the toxicity and concentration of the detected chemical features even if these have not yet been fully structurally elucidated. Combining these predictions enables us to focus on the chemical features possessing high risk.</p><h5><strong>Role of AI in the identification of emerging food systems risks</strong></h5><ul><li>Ákos Bernard Jóźwiak from Syreon Research Institute, Budapest, Hungary</li></ul><p>AI-assisted evidence synthesis – spanning curated scientific evidence, exposome data, and network analysis – is the backbone of next-generation emerging chemical food safety risk identification, enabling earlier signals and more resilient surveillance systems.</p><h5><strong>Challenges of microplastics analysis in the context of food safety</strong></h5><ul><li>Dorte Herzke from Norwegian Institute of Public Health, Oslo, Norway</li></ul><p>Food and food packaging are major sources of micro- and nanoplastic exposure. Plastics used in processing, storage, and packaging can release particles through heat, abrasion, and degradation. Small particles below 2 µm may cross gut barriers and carry chemicals, highlighting the need for robust and sensitive measurement methods.</p><h5><strong>Never-ending analytical challenges in PFAS analysis of food</strong></h5><ul><li>Darina Dvořáková from University of Chemistry and Technology Prague, Prague, Czechia</li></ul><p>Exploring and monitoring PFAS in food requires advanced strategies. Combining targeted, suspect, and non-target HRMS analysis, determination of total fluorine and sum parameters, and novel sensors provides new insights into PFAS occurrence and supports food safety monitoring.</p><h5><strong>An overview of the latest scientific knowledge on process contaminants in food for appropriate risk management measures</strong></h5><ul><li>Thierry Delatour from Nestlé Research, Lausanne, Switzerland.</li></ul><p>Recent scientific findings related to acrylamide and furans formation, occurrence and analytical methods in food provide important insights for risk management.</p>

Deadline for RAFA 2026 Early Registration and Oral Abstract Submission is approaching

<p><strong>Our Library never stops expanding. What are the most recent contributions to LabRulezICPMS Library in the week of 22nd June 2026? Check out new documents from the field of spectroscopy/spectrometry and related techniques!</strong></p><blockquote><p><span style="font-size:20px;">👉 </span><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/library"><span style="font-size:20px;"><strong>SEARCH THE LARGEST REPOSITORY OF DOCUMENTS ABOUT SPECTROSCOPY/SPECTROMETRY RELATED TECHNIQUES</strong></span></a></p></blockquote><blockquote><p><strong>👉 Need info about different analytical techniques?</strong> Peek into <a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/library"><strong>LabRulezLCMS</strong></a> or <a target="_blank" rel="noopener noreferrer" href="https://gcms.labrulez.com/library"><strong>LabRulezGCMS</strong></a> libraries.</p></blockquote><p>This week we bring you technical note by <strong>Agilent Technologies</strong>, application note by <strong>Shimadzu </strong>and other document by <strong>Thermo Fisher Scientific!</strong></p><h3><strong>1. Agilent Technologies: Dual-Cell System (DCS) and Advanced Helium Mode (AHM)</strong></h3><p><strong>Technological developments for higher sensitivity and better interference removal than traditional He-KED</strong></p><ul><li>Technical note</li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/labrulez-bucket-strapi-h3hsga3/te_batch_conversion_tool_9500_icp_ms_5994_9214en_agilent_0a1bba76e2.pdf"><strong>Full PDF for download</strong></a></li></ul><h4><strong>Evolution of Agilent’s Collision Reaction Cell (CRC) technology&nbsp;</strong></h4><ul><li><strong>2001: </strong>Launched the first ICP-MS with CRC—the Agilent 7500c with Octopole Reaction System (ORS)&nbsp;</li><li><strong>2011:</strong> Introduced High Energy Helium Mode (HEHe) using Collision Induced Dissociation (CID)&nbsp;</li><li><strong>2012: </strong>Released the world’s first Triple Quadrupole ICP-MS—the Agilent 8800 ICP-QQQ&nbsp;</li><li><strong>2016:</strong> Launched the second generation Triple Quadrupole ICP-MS with Axial Acceleration—the Agilent 8900 ICP-QQQ&nbsp;</li><li><strong>2026: </strong>Introduced the innovative Dual-Cell System (DCS) and Advanced Helium Mode (AHM) for the Agilent 9500 ICP-QQQ</li></ul><p>Collision/Reaction Cell (CRC) technology is now a standard feature in modern ICP-MS systems, providing a reliable means of eliminating spectral interferences that compromise data quality. ICP-MS systems with integrated CRCs range from single quadrupole (SQ) ICP-MS used in environmental and food analysis, to triple quadrupole ICP-MS (ICP-QQQ) for advanced research applications. For routine applications, Helium Kinetic Energy Discrimination (He KED) mode, commonly referred to as helium mode (He mode), is the most widely used CRC operational mode. The widespread use of He mode is due to its universal effectiveness in reducing a broad range of polyatomic interferences without the need for element-specific optimization.&nbsp;</p><p>Unlike CRCs that rely on reactive cell gases and require complex tuning (often referred to as reaction cells), He mode effectively mitigates many commonly occurring polyatomic ion interferences without the need for intricate adjustments. In contrast, reaction cells often require careful selection of gas type (such as ammonia or oxygen) and tuning parameters based on the specific interfering ions on analytes of interest.&nbsp;</p><p>Building on the simplicity of He mode, Agilent has developed Advanced Helium Mode (AHM) for the <a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/library?mainauthorItems=10&amp;search=9500"><strong>Agilent 9500 Triple Quadrupole ICP-MS (ICP-QQQ)</strong></a>. AHM represents a breakthrough in interference removal technology, enabled by the newly designed Agilent Dual-Cell System (DCS) and high-speed cell voltage control. These innovations deliver high sensitivity across the mass range and superior interference removal performance for routine applications. Compared to conventional He mode, AHM demonstrates the following improvements:</p><ul><li>Around a 20-fold sensitivity improvement for low-mass elements, such as beryllium (Be) and boron (B)&nbsp;</li><li>Around a 2-fold improvement for mid-to-high mass elements&nbsp;</li><li>A reduction of more than 33% in data acquisition time while maintaining detection limits (DLs), accelerating analytical measurement times&nbsp;</li></ul><p>AHM not only replaces traditional He KED but also consolidates multiple tuning modes including no gas, He, and HEHe into a single, streamlined mode. Integrated into the 9500 ICP-QQQ, AHM is a next-generation standard He mode that is faster, simpler, and delivers higher performance than its predecessor. This technical note describes the performance enhancement mechanisms of the DCS and AHM. It also includes some comparative results with conventional He KED mode to highlight the analytical improvements of AHM.</p><h4><strong>Overview and advantages of AHM&nbsp;</strong></h4><p>Typically, multi-element ICP-MS methods apply no gas mode to the determination of low-mass elements like Be and B due to low sensitivity in traditional He KED mode. Consequently, many routine ICP-MS applications have required multiple tune setups, combining no gas, He, and HEHe. Each mode switch introduces a delay due to cell pressure stabilization requirements.&nbsp;</p><p>In practice, low-mass elements (m/z &lt; 23) are generally unaffected by polyatomic ion interferences, so KED is often unnecessary. Therefore, in AHM, different voltages are applied to the DCS (effectively disabling KED) for low-mass elements, while keeping standard settings for elements with m/z ≥ 23.&nbsp;</p><p>The DCS voltages are dynamically switched in sync with Q2 using a high-speed voltage control circuit, providing over 20× sensitivity improvement for low-mass elements compared to conventional He mode. AHM eliminates the need to run in no gas mode, greatly simplifying the method. As a default approach, AHM alone is suitable for most applications.<sup>1</sup></p><h3><strong>2. Shimadzu: Damping Force Characteristic Test of Suspension Struts [JASO C611]</strong></h3><ul><li>Application note</li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/labrulez-bucket-strapi-h3hsga3/an_01_01017_en_2fbbb9c247.pdf"><strong>Full PDF for download</strong></a></li></ul><h5><strong>User Benefits</strong></h5><ul><li>Damping force characteristic tests on suspension struts can be performed based on the JASO C611 standard.&nbsp;</li><li>Combination test enables automatic speed change and measurement.&nbsp;</li><li>High responsiveness of the EMT series enables testing at high excitation speed.</li></ul><p>Various components play an important role in achieving a comfortable ride in vehicles. Among them, the suspension strut used in the suspension system is an important component that stabilizes the vehicle body by mitigating the impact caused by uneven road surfaces.&nbsp;</p><p>“JASO C611 Suspension Struts for Automobiles”1), a standard of JASO (Japanese Automotive Standards Organization), established by JSAE, specifies the definition, quality, and test method for suspension struts. There is no international standard that is equivalent to JASO C611.&nbsp;</p><p>In order to improve the performance of suspension struts, it is necessary to measure the damping force against speed by changing the excitation speed. The performance of suspension struts can be confirmed by measuring the response, such as the relationship between speed and damping force and the Lissajous waveform.&nbsp;</p><p>This article introduces an example of the test method “Damping Force Characteristic Test” specified in JASO C611, which was conducted on a Shimadzu EMT series electromagnetic fatigue testing machine.</p><h4><strong>Testing Equipment&nbsp;</strong></h4><p>The EMT-1kNV-50 electromagnetic dynamic and fatigue testing machine was used in this test. Fig. 1 shows a photograph of the testing machine. The electromagnetic actuator with extremely high frequency response enables highly accurate dynamic testing. In this test, the maximum test speed was 0.6 m/s. The EMT seriesis most suitable for testing at such high frequencies.</p><h4><strong>Conclusion&nbsp;</strong></h4><p>A damping force characteristic test on a suspension strut based on JASO C611 was conducted using an EMT series electromagnetic fatigue testing machine and Windows software for 4830. The test conditions were set using the excitation speed, and it was confirmed that the test was accurately controlled as set. The standard “JASO C611 Suspension Struts for Automobiles” referred to this time is derived from “JASO C602 Automotive Parts - Telescopic Shock Absorbers for Suspension Systems”2). Although C602 also prescribes a damping force characteristic test, it is almost equivalent to the C611, and the test machine configuration can be used by replacing the jig.</p><h3><strong>3. Thermo Fisher Scientific: </strong><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/products/2206"><strong>Hypulse Surface Analysis System</strong></a></h3><ul><li>Other document</li><li><a target="_blank" rel="noopener noreferrer" href="https://icpms.labrulez.com/labrulez-bucket-strapi-h3hsga3/Hypulse_DS_0516_EN_05_2025_1998238_WEB_0e44628a5e.pdf"><strong>Full PDF for download</strong></a></li></ul><h4><strong>Key features&nbsp;</strong></h4><ul><li><strong>Unique depth profiling capability</strong>. The femtosecond laser ablation system provides controlled material removal without inducing chemical damage to your sample.&nbsp;</li><li><strong>Fast, efficient XPS</strong>. Quick sample pump-down times, a unique sample viewing system, and high sensitivity for all analysis areas help ensure exceptional data quality, even for highly challenging samples.&nbsp;</li><li><strong>Co-incident additional spectroscopy</strong>. Optimize the information obtained from features of interest with the addition of optional analytical techniques, including ion scattering spectroscopy, reflected electron energy loss spectroscopy, and UV photoelectron spectroscopy.&nbsp;</li><li><strong>Fully featured software. </strong>The latest version of the Avantage Data System is included for data collection and analysis, with the ability to import data into Thermo Scientific Maps Software for correlation with electron microscopy images.</li></ul><h4><strong>Technical highlights&nbsp;</strong></h4><h5><strong>Micro-focused, monochromated aluminum K-alpha X-ray source&nbsp;</strong></h5><ul><li>Computer-controlled quartz-crystal monochromator&nbsp;</li><li>Software-adjustable spot size&nbsp;</li><li>Spot size range: 10–400 μm&nbsp;</li><li>Motorized, water-cooled anode with 16 positions&nbsp;</li></ul><h5><strong>Electron optics and analyzer</strong></h5><ul><li>Electrostatic objective lens&nbsp;</li><li>Full 180° hemispherical μ-metal shielded analyzer&nbsp;</li><li>Continuously selectable pass energy: 1–400 eV&nbsp;</li><li>128-channel, signature-corrected, positionsensitive detector&nbsp;</li><li>Automatic energy scale and transmission function calibration&nbsp;</li></ul><h5><strong>Charge compensation system&nbsp;</strong></h5><ul><li>Patented dual-beam electron and ion source&nbsp;</li><li>Beam energy for charge compensation: 0–5 eV&nbsp;</li></ul><h5><strong>Femtosecond-laser ablation system&nbsp;</strong></h5><ul><li>Fully integrated 1,030 nm pulsed femtosecond-laser source&nbsp;</li><li>Class 1 laser system&nbsp;</li><li>Tunable pulse energy up to 1 mJ&nbsp;</li><li>Computer-controlled attenuation optimizes ablation conditions&nbsp;</li><li>Beam imaging module for system calibration and alignment</li></ul>

News from LabRulezICPMS Library - Week 26, 2026

Article

Events

Application

Academy

RAFA provides an overview of contemporary trends in ANALYTICAL & BIOANALYTICAL STRATEGIES IN FOOD QUALITY AND SAFETY CONTROL and discusses CHALLENGES / NOVEL APPROACHES IN FOOD AND NATURAL PRODUCTS ANALYSIS.

Recent Advances in Food Analysis (RAFA)

Eurachem is a European network promoting international traceability of chemical measurements and good analytical practice. It provides expert guidance, supports method validation, uncertainty evaluation, proficiency testing, and facilitates discussion on technical and policy issues in analytical quality.

Eurachem

Everything from the world of analytical chemistry in one place. We connect people in solving their problems. At Labrulez you will find all the necessary information easily, quickly and clearly. Stop searching and start finding.

LabRulez

Waters Aura+ System for particle characterization

Fast, decisive particle characterization for biologics. Aura+ delivers high-throughput, 5 µL analysis with BMI and FMM imaging for proteins, antibodies, and cell/gene therapies.

<h4><strong>Fast, decisive, low-volume particle characterization analysis for biotherapeutic workflows</strong></h4><p><strong>When you need the flexibility to conduct particle characterization analyses on different types of biologics, including protein and antibody therapeutics, cell therapies, and gene therapies, the Aura+ System has you covered.</strong></p><p>Fully configured to support applications across protein, antibody, cell, and gene therapy workflows, Aura+ brings particle characterization to earlier stages of therapeutic development, so you can make better decisions sooner.</p><p>Powered by the backgrounded membrane imaging (BMI) and fluorescence membrane microscopy (FMM) technology shared within the Aura family of instruments, Aura+ System enables applications from late discovery to development and manufacturing, enhancing decision-making and accelerating your success.</p><p><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Waters_Aura_System_18b9a5e9f5.jpg" alt="Waters: Aura+ System" srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Waters_Aura_System_18b9a5e9f5.jpg 234w," sizes="100vw" width="1024" height="682"></p><h4><strong>Specifications</strong></h4><ul><li><strong>Imaging area: </strong>24.6 mm2</li><li><strong>Optics: </strong>4x and 20x objectives</li><li><strong>Minimum volume:</strong> 5 µL (assay dependent)</li><li><strong>Resolution:</strong> 1.0 pixel/µm</li><li><strong>Detectable size range: </strong>Range from &gt;1 µm (ECD) to &lt;5 mm (ECD)</li><li><strong>BMI read time: </strong>1 minute/sample</li><li><strong>FMM read time:</strong> 3 FL channels, 30 seconds/sample</li><li><strong>Software:</strong> Particle VUE 4.x all-in-one software suite (image capture and analysis)</li></ul><h4><strong>Overview</strong></h4><ul><li>Save precious material with just 5 µL sample volume requirements&nbsp;</li><li>Get actionable results from a full 96 well plate of labeled samples to data in just 90 minutes</li><li>Boost efficiency with 96-well membrane plate high-throughput capability</li><li>Gain deeper particle insights with advanced imaging</li><li>Rely only on one platform for proteins, antibodies, and cell and gene therapies development</li></ul><p><strong>Recommended Use: </strong>For workflows requiring complete flexibility across a full spectrum of analytes, including biologics, viral vectors, cells, and other contaminants.​</p><h4><strong>Take the guesswork out of your aggregate ID</strong></h4><p>Don’t waste time troubleshooting incorrectly identified aggregates in your therapeutic. Aura+ System uses a combination of brightfield and fluorescent imaging to specifically ID and quantitate cell, viral capsid, protein, degraded excipients, and packaging contaminants so you’ll know exactly what’s in your sample.​</p><p>With high-throughput 96-well plate capability, 5 µL sample volumes, and results in as little as 90 minutes, it offers an efficient solution for detailed particle analysis, meeting USP &lt;788&gt; and &lt;1788&gt; requirements.</p><p><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Waters_Aura_Identify_cell_doublets_and_triplets_1_cellular_aggregates_2_protein_aggregates_3_and_plastic_contaminants_4_in_a_cell_therapeutic_sample_5227e05a6d.jpg" alt="Waters: Aura+ System - Identify cell doublets and triplets (1), cellular aggregates (2), protein aggregates (3), and plastic contaminants (4) in a cell therapeutic sample." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Waters_Aura_Identify_cell_doublets_and_triplets_1_cellular_aggregates_2_protein_aggregates_3_and_plastic_contaminants_4_in_a_cell_therapeutic_sample_5227e05a6d.jpg 234w," sizes="100vw" width="1024" height="682"></p><h4><strong>BMI: The key to sensitive, robust, early-stage particle characterization</strong></h4><p>Backgrounded membrane imaging (BMI) provides a clearer, faster, and more comprehensive view of what’s really in your sample. By capturing and subtracting background images of the membrane, BMI achieves 10x greater contrast than liquid-based measurements such as light obscuration and flow imaging. Aura+ System provides aggregate data without any clogging concerns or the need for cleaning between measurements.</p><p><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Waters_Aura_BMI_achieves_10x_greater_contrast_than_liquid_based_measurements_such_as_light_obscuration_and_flow_imaging_06d3a7349c.jpg" alt="Waters: Aura+ System - BMI achieves 10x greater contrast than liquid-based measurements such as light obscuration and flow imaging." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Waters_Aura_BMI_achieves_10x_greater_contrast_than_liquid_based_measurements_such_as_light_obscuration_and_flow_imaging_06d3a7349c.jpg 234w," sizes="100vw" width="1024" height="682"></p><h4><strong>Get fast, definitive particle identification with three fluorescence channels</strong></h4><p>The Aura+ System comes with three fluorescence channels so you can get the same information from one experiment that would otherwise take three different studies.</p><p>In addition, The Aura+ System definitively identifies different types of particles within the same sample for more reliable decision-making:</p><ul><li>Three fluorescence membrane microscopy (FMM) channels for three different species of organic particles</li><li>Side illumination membrane imaging (SIMI) channel for extrinsic and inorganic particles</li><li>Ideal for applications including polysorbate degradation, particulate contamination, protein &amp; antibody workflows, cell therapy workflows, AAV aggregation, AAV stability, cell therapy QC, and cell viability</li></ul><p><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Waters_Aura_Cells_protein_aggregate_and_ig_G_via_immunoassay_6c3e43ecc4.jpg" alt="Waters: Aura+ System - Cells, protein aggregate, and igG (via immunoassay)." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Waters_Aura_Cells_protein_aggregate_and_ig_G_via_immunoassay_6c3e43ecc4.jpg 234w," sizes="100vw" width="1024" height="682"></p><h4><strong>Obtain clear details with high magnification</strong></h4><p>With the high magnification capabilities of the Aura+ System, you can see more morphological detail of unlabeled particles, enabling decisive discrimination between your lead and undesirable particles.</p><p><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Waters_Aura_Quickly_differentiate_and_enumerate_cells_versus_Dynabeads_quantify_polysorbate_degradation_and_more_b3e24050f2.jpg" alt="Waters: Aura+ System - Quickly differentiate and enumerate cells versus Dynabeads™, quantify polysorbate degradation, and more." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Waters_Aura_Quickly_differentiate_and_enumerate_cells_versus_Dynabeads_quantify_polysorbate_degradation_and_more_b3e24050f2.jpg 234w," sizes="100vw" width="1024" height="682"></p>

Waters Aura PTx System for particle characterization

Aura PTx combines BMI and fluorescence microscopy to rapidly detect protein aggregates and polysorbate degradation from just 5 µL of sample.

<p><strong>The Aura PTx System is an innovative analytical platform designed to accelerate protein formulation development and stability screening for therapeutic drug development. Combining Backgrounded Membrane Imaging (BMI) and Fluorescence Membrane Microscopy (FMM) with dual fluorescence channels, the system enables rapid detection, counting, and characterization of protein aggregates and excipient degradation products within a single experiment.</strong></p><p>Unlike traditional imaging methods that rely solely on particle morphology, Aura PTx can distinguish protein and non-protein particles using fluorescence-based identification. The combination of <strong>Thioflavin T (ThT)</strong> and <strong>BODIPY FL C16</strong> staining enables simultaneous assessment of protein aggregation and polysorbate degradation, two critical indicators of biologic formulation stability.</p><p>Requiring only 5 µL of sample and supporting automated 96-well plate workflows, the Aura PTx System is ideally suited for high-throughput formulation screening during early-stage development of therapeutic proteins, monoclonal antibodies, and other biologics.</p><h3><strong>Key Features</strong></h3><ul><li>Combines BMI and FMM technologies in one platform</li><li>Dual fluorescence channels for simultaneous analysis</li><li>Distinguishes protein and non-protein particles</li><li>Detects and quantifies protein aggregates</li><li>Monitors polysorbate degradation</li><li>Simultaneous protein and excipient stability assessment</li><li>Requires only 5 µL sample volume</li><li>Automated 96-well plate workflow</li><li>High-throughput formulation screening</li><li>No cleaning required between measurements</li><li>Fast sample processing and analysis</li><li>Suitable for Design of Experiments (DoE)</li><li>Supports biologics development</li><li>Early detection of formulation stability issues</li></ul><h3><strong>Technical Specifications</strong></h3><h4><strong>Technology</strong></h4><ul><li>Backgrounded Membrane Imaging (BMI)</li><li>Fluorescence Membrane Microscopy (FMM)</li><li>Dual-channel fluorescence detection</li></ul><h4><strong>Optics</strong></h4><ul><li>Objective: 4×</li><li>Resolution: 1.0 pixel/µm</li><li>Imaging area: 24.6 mm²</li></ul><h4><strong>Particle Detection</strong></h4><ul><li>Detectable size range:<ul><li>1 µm (ECD)</li><li>&lt;5 mm (ECD)</li></ul></li></ul><h4><strong>Sample Handling</strong></h4><ul><li>Minimum sample volume: 5 µL</li><li>Compatible with 96-well plates</li><li>Optimized for high-throughput screening</li></ul><h4><strong>Analysis Speed</strong></h4><ul><li>BMI read time: 1 minute per sample</li><li>FMM read time: 30 seconds per sample</li></ul><h4><strong>Fluorescence Analysis</strong></h4><ul><li>Thioflavin T (ThT) for protein aggregate detection</li><li>BODIPY FL C16 for polysorbate degradation analysis</li><li>Simultaneous protein and excipient characterization</li></ul><p><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Waters_The_Aura_P_Tx_System_tells_you_exactly_what_is_protein_via_Th_T_staining_and_what_is_not_even_in_mixed_particles_9cb34b80b1.jpg" alt="Waters: The Aura PTx System tells you exactly what is protein (via ThT staining) and what is not, even in mixed particles." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Waters_The_Aura_P_Tx_System_tells_you_exactly_what_is_protein_via_Th_T_staining_and_what_is_not_even_in_mixed_particles_9cb34b80b1.jpg 234w," sizes="100vw" width="1024" height="682"></p><p><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Waters_The_Aura_P_Tx_System_is_the_first_to_use_thioflavin_T_Th_T_and_BODIPY_FL_C16_staining_to_detect_and_quantify_protein_aggregates_and_polysorbate_breakdown_fc113affba.jpg" alt="Waters: The Aura PTx System is the first to use thioflavin T (ThT) and BODIPY FL C16 staining to detect and quantify protein aggregates and polysorbate breakdown." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Waters_The_Aura_P_Tx_System_is_the_first_to_use_thioflavin_T_Th_T_and_BODIPY_FL_C16_staining_to_detect_and_quantify_protein_aggregates_and_polysorbate_breakdown_fc113affba.jpg 234w," sizes="100vw" width="1024" height="682"></p><h4><strong>Software</strong></h4><ul><li>Particle Vue™ 4.x Software Suite</li><li>Integrated data analysis</li><li>Automated particle identification and characterization</li></ul><h4><strong>Typical Applications</strong></h4><ul><li>Biopharmaceutical development</li><li>Protein formulation screening</li><li>Monoclonal antibodies</li><li>Biosimilars</li><li>Stability studies</li><li>Excipient screening</li><li>Polysorbate degradation monitoring</li><li>Aggregate characterization</li><li>Design of Experiments (DoE)</li><li>Biologics quality control</li></ul>

Waters Aura GT System for particle characterization

Aura GT enables characterization of AAV and viral vectors from just 5 µL of sample, including detection of capsid and DNA aggregates using BMI and FMM technologies.

<p><strong>The Aura GT System is the first dedicated platform designed for the detection, counting, and characterization of viral vectors used in gene therapy, including AAV (Adeno-Associated Virus) and lentiviral vectors. Combining Backgrounded Membrane Imaging (BMI) and Fluorescence Membrane Microscopy (FMM) with dual fluorescence channels, the system enables rapid and reliable assessment of viral particle aggregation and stability during early-stage development.</strong></p><p>Requiring only <strong>5 µL of sample</strong>, Aura GT allows characterization even when only limited material is available. Using fluorescent dyes such as <strong>Thioflavin T (ThT)</strong> and <strong>SYBR™ Gold</strong>, researchers can distinguish capsid aggregates from DNA-containing aggregates, identify root causes of instability, and gain valuable insights into viral vector quality.</p><p>The system supports high-throughput 96-well plate screening and enables direct comparison of formulations, AAV serotypes, production lots, storage conditions, and stability profiles. Results that traditionally required months of work can now be obtained within hours.</p><h3><strong>Key Features</strong></h3><ul><li>Combines <strong>BMI and FMM technologies</strong> in one platform</li><li>Specifically designed for <strong>AAV, lentivirus, and viral vectors</strong></li><li>Detects, counts, and characterizes viral aggregates</li><li>Differentiates <strong>capsid and DNA aggregates</strong></li><li>Identifies root causes of aggregation and instability</li><li>Requires only <strong>5 µL sample volume</strong></li><li>Dual fluorescence channels for simultaneous characterization</li><li>High-throughput <strong>96-well plate screening</strong></li><li>Direct comparison of formulations, serotypes, and production lots</li><li>Viral vector stability assessment</li><li>Actionable results within hours</li><li>Eliminates labor-intensive traditional assays</li><li>Optimized for gene therapy development</li><li>High sensitivity and throughput</li></ul><h3><strong>Technical Specifications</strong></h3><h4><strong>Technology</strong></h4><ul><li>Backgrounded Membrane Imaging (BMI)</li><li>Fluorescence Membrane Microscopy (FMM)</li><li>Dual-channel fluorescence detection</li></ul><h4><strong>Optics</strong></h4><ul><li><strong>Objective:</strong> 4×</li><li><strong>Resolution: </strong>1.0 pixel/µm</li><li><strong>Imaging area: </strong>24.6 mm²</li></ul><h4><strong>Particle Detection</strong></h4><ul><li>Detectable size range:<ul><li>1 µm (ECD)</li><li>&lt;5 mm (ECD)</li></ul></li></ul><h4><strong>Sample Handling</strong></h4><ul><li><strong>Minimum sample volume: </strong>5 µL</li><li><strong>Compatible with 96-well plates</strong></li><li>Optimized for high-throughput screening</li></ul><p><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Waters_Get_your_gene_therapy_products_to_market_even_faster_with_Aura_GT_System_195d42d00b.jpg" alt="Waters: Get your gene therapy products to market even faster with Aura GT System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Waters_Get_your_gene_therapy_products_to_market_even_faster_with_Aura_GT_System_195d42d00b.jpg 245w," sizes="100vw" width="1024" height="522"></p><h4><strong>Analysis Speed</strong></h4><ul><li><strong>BMI read time:</strong> 1 minute per sample</li><li><strong>FMM read time: </strong>30 seconds per sample</li><li>2 fluorescence channels</li></ul><h4><strong>Fluorescence Analysis</strong></h4><ul><li>Thioflavin T (ThT) for capsid aggregate detection</li><li>SYBR™ Gold for DNA detection</li><li>Simultaneous identification of protein and DNA aggregates</li></ul><p><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Waters_Identify_root_cause_and_characterize_AAV_particles_at_low_volume_with_Aura_GT_System_c3f1c6a334.jpg" alt="Waters: Identify root cause and characterize AAV particles at low volume with Aura GT System." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Waters_Identify_root_cause_and_characterize_AAV_particles_at_low_volume_with_Aura_GT_System_c3f1c6a334.jpg 234w," sizes="100vw" width="1024" height="683"></p><h4><strong>Software</strong></h4><ul><li>Particle Vue™ 4.x Software Suite</li><li>Image acquisition and analysis</li><li>Automated particle characterization</li></ul><h4><strong>Typical Applications</strong></h4><ul><li>Gene therapy development</li><li>AAV vector characterization</li><li>Lentiviral vectors</li><li>Stability studies</li><li>Aggregation studies</li><li>AAV serotype comparison</li><li>Formulation screening</li><li>Production lot evaluation</li><li>DNA aggregate analysis</li><li>Viral vector development</li></ul>

Waters Aura CL System for particle characterization

Waters Aura CL rapidly identifies cells, aggregates, and residual Dynabeads™ from just 5 µL of sample while assessing viability and purity in cell therapy workflows.

<p><strong>The Aura CL System is the first dedicated platform designed for rapid identification, counting, and characterization of subvisible particles in cell therapy development and manufacturing. Unlike traditional methods, it can reliably distinguish viable cells, unwanted particles, protein aggregates, and manufacturing-related contaminants such as Dynabeads™, while simultaneously providing cell counts, viability information, and sample purity assessment.</strong></p><p>The system combines <strong>Backgrounded Membrane Imaging (BMI)</strong>, <strong>Fluorescence Membrane Microscopy (FMM)</strong>, and <strong>Side Illumination Membrane Imaging (SIMI)</strong> technologies to deliver fast, automated particle analysis without subjective operator interpretation. Through fluorescence labeling, users can clearly differentiate cellular from non-cellular particles, protein from non-protein aggregates, and various cell populations within complex samples.</p><p>Requiring only <strong>5 µL of sample</strong>, Aura CL supports high-throughput screening and can analyze up to 96 samples in less than one hour, making it an ideal solution for cell therapy development, manufacturing, and quality control workflows.</p><h3><strong>Key Features</strong></h3><ul><li>Combines <strong>BMI, FMM, and SIMI </strong>technologies</li><li>Automated identification of <strong>cells and non-cell particles</strong></li><li>Detection and counting of residual<strong> Dynabeads™</strong></li><li>Cell viability assessment</li><li>Characterization of subvisible particles</li><li>Differentiates <strong>protein and non-protein aggregates</strong></li><li>Distinguishes<strong> cellular and non-cellular particles</strong></li><li>Requires only<strong> 5 µL sample volume</strong></li><li>High-throughput <strong>96-well plate screening</strong></li><li>Fully automated analysis workflow</li><li>Results within minutes</li><li>Supports cell therapy development and manufacturing</li><li>Greater accuracy than manual hemocytometry</li><li>Reduces human interpretation errors</li></ul><h3><strong>Technical Specifications</strong></h3><h4><strong>Technology</strong></h4><ul><li>Backgrounded Membrane Imaging (BMI)</li><li>Fluorescence Membrane Microscopy (FMM)</li><li>Side Illumination Membrane Imaging (SIMI)</li></ul><h4><strong>Optics</strong></h4><ul><li><strong>Objectives:</strong><ul><li>4×</li><li>10×</li></ul></li><li><strong>Resolution: </strong>1.0 pixel/µm</li><li><strong>Imaging area:</strong> 24.6 mm²</li></ul><h4><strong>Particle Detection</strong></h4><ul><li>Detectable size range:<ul><li>1 µm (ECD)</li><li>&lt;5 mm (ECD)</li></ul></li></ul><h4><strong>Sample Handling</strong></h4><ul><li><strong>Minimum sample volume: </strong>5 µL</li><li>Compatible with 96-well plates</li><li>Optimized for high-throughput screening</li></ul><h4><strong>Analysis Speed</strong></h4><ul><li><strong>BMI read time: </strong>1 minute per sample</li><li><strong>FMM read time: </strong>30 seconds per sample</li></ul><h4><strong>Fluorescence Analysis</strong></h4><ul><li>Cell and non-cell particle identification</li><li>Cell viability measurements</li><li>Protein aggregate detection</li><li>Non-protein particle detection</li><li>Fluorescent antibody and cell labeling applications</li></ul><p><img src="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/Waters_With_Aura_CL_System_you_can_achieve_high_throughput_and_definitive_identification_of_viable_cells_and_take_the_guesswork_out_of_cell_viability_assessments_a46a5ee8b4.jpg" alt="Waters: With Aura CL System, you can achieve high-throughput and definitive identification of viable cells and take the guesswork out of cell viability assessments." srcset="https://storage.googleapis.com/labrulez-bucket-strapi-h3hsga3/thumbnail_Waters_With_Aura_CL_System_you_can_achieve_high_throughput_and_definitive_identification_of_viable_cells_and_take_the_guesswork_out_of_cell_viability_assessments_a46a5ee8b4.jpg 234w," sizes="100vw" width="1024" height="682"></p><h4><strong>Software</strong></h4><ul><li>Particle Vue™ 4.x Software Suite</li><li>Image acquisition and analysis</li><li>Automated particle classification</li><li>Viability and purity assessment tools</li></ul><h4><strong>Typical Applications</strong></h4><ul><li>Cell therapy development</li><li>CAR-T manufacturing</li><li>Cell product quality control</li><li>Residual Dynabeads™ detection</li><li>Cell viability testing</li><li>Cell culture purity monitoring</li><li>Subvisible particle characterization</li><li>Biologics development</li><li>Lot release testing</li><li>Manufacturing process control</li></ul>

Products focused on Particle characterization - page 1

Related content

News from LabRulezICPMS Library - Week 26, 2026

Deadline for RAFA 2026 Early Registration and Oral Abstract Submission is approaching

Let’s call a PT scheme a PT scheme!